JESSICA RIPIC: Open Payments
NPI 1841918000 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,698 in 96 payments from 25 companies in 2025. Trend: 2023 $535 · 2024 $4,216 · 2025 $2,698
Food & beverage: $2,508Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $365 |
| Novartis Pharmaceuticals Corporation | 15 | $269 |
| Incyte Corporation | 4 | $251 |
| AstraZeneca Pharmaceuticals LP | 10 | $200 |
| GlaxoSmithKline, LLC. | 4 | $186 |
| Merck Sharp & Dohme LLC | 6 | $156 |
| E.R. Squibb & Sons, L.L.C. | 3 | $149 |
| PFIZER INC. | 7 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $110 |
| Regeneron Healthcare Solutions, Inc. | 1 | $105 |
Products named: RYBREVANT, OJJAARA, KEYTRUDA, JAKAFI, REBLOZYL, KISQALI, LIBTAYO, Padcev.
Industry payments across NY — which companies pay providers there.
